Search Results - "Stumpp, T."
-
1
Half-life extension using serum albumin-binding DARPin® domains
Published in Protein engineering, design and selection (01-09-2017)“…Abstract A long systemic half-life is key for therapeutic proteins. To that end we have generated serum albumin-binding designed ankyrin repeat domains. These…”
Get full text
Journal Article -
2
High-affinity binders selected from designed ankyrin repeat protein libraries
Published in Nature biotechnology (01-05-2004)“…We report here the evolution of ankyrin repeat (AR) proteins in vitro for specific, high-affinity target binding. Using a consensus design strategy, we…”
Get full text
Journal Article -
3
DARPins: A new generation of protein therapeutics
Published in Drug discovery today (01-08-2008)“…DARPins (designed ankyrin repeat proteins) are a novel class of binding molecules with the potential to overcome limitations of monoclonal antibodies, hence…”
Get full text
Journal Article -
4
Comprehensive Survey of Proteins Targeted by Chloroplast Thioredoxin
Published in Proceedings of the National Academy of Sciences - PNAS (25-09-2001)“…Possible target proteins of chloroplast thioredoxin (Trx) have been investigated in the stroma lysate of spinach chloroplasts. For that purpose, we immobilized…”
Get full text
Journal Article -
5
Designing Repeat Proteins: Well-expressed, Soluble and Stable Proteins from Combinatorial Libraries of Consensus Ankyrin Repeat Proteins
Published in Journal of molecular biology (12-09-2003)“…We describe an efficient way to generate combinatorial libraries of stable, soluble and well-expressed ankyrin repeat (AR) proteins. Using a combination of…”
Get full text
Journal Article -
6
Beyond Antibodies: The DARPin® Drug Platform
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01-08-2020)Get full text
Journal Article -
7
Designed to Be Stable: Crystal Structure of a Consensus Ankyrin Repeat Protein
Published in Proceedings of the National Academy of Sciences - PNAS (18-02-2003)“…Ankyrin repeat (AR) proteins mediate innumerable protein-protein interactions in virtually all phyla. This finding suggested the use of AR proteins as designed…”
Get full text
Journal Article -
8
Efficient Tumor Targeting with High-Affinity Designed Ankyrin Repeat Proteins: Effects of Affinity and Molecular Size
Published in Cancer research (Chicago, Ill.) (15-02-2010)“…Slow-clearing, tumor-targeting proteins such as monoclonal antibodies typically exhibit high tumor accumulation but low tissue contrast, whereas…”
Get full text
Journal Article -
9
A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma
Published in EJHaem (01-10-2024)“…MP0250 is a designed ankyrin repeat protein that specifically inhibits both vascular endothelial growth factor A (VEGF‐A) and hepatocyte growth factor (HGF),…”
Get full text
Journal Article -
10
Designing Repeat Proteins: Modular Leucine-rich Repeat Protein Libraries Based on the Mammalian Ribonuclease Inhibitor Family
Published in Journal of molecular biology (12-09-2003)“…We present a novel approach to design repeat proteins of the leucine-rich repeat (LRR) family for the generation of libraries of intracellular binding…”
Get full text
Journal Article -
11
Intracellular Kinase Inhibitors Selected from Combinatorial Libraries of Designed Ankyrin Repeat Proteins
Published in The Journal of biological chemistry (01-07-2005)“…The specific intracellular inhibition of protein activity at the protein level allows the determination of protein function in the cellular context. We…”
Get full text
Journal Article -
12
Consensus Design of Repeat Proteins
Published in Chembiochem : a European journal of chemical biology (06-02-2004)“…Consensus design is a valuable protein-engineering method that is based on statistical information derived from sequence alignments of homologous proteins…”
Get full text
Journal Article -
13
Signal sequences directing cotranslational translocation expand the range of proteins amenable to phage display
Published in Nature biotechnology (01-07-2006)Get full text
Journal Article -
14
Carnitine partially protects the rat testis against the late damage produced by doxorubicin administered during pre‐puberty
Published in Andrology (Oxford) (01-11-2014)“…Summary Doxorubicin, an anticancer drug, is widely included in chemotherapy protocols to combat childhood cancer. Carnitine, an important quaternary amine, is…”
Get full text
Journal Article -
15
Beyond Antibodies: The DARPin® Drug Platform
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01-08-2020)“…The DARPin ® drug platform was established with a vision to expand the medical use of biologics beyond what was possible with monoclonal antibodies. It is…”
Get full text
Journal Article -
16
Effects of prenatal and lactation nicotine exposure on rat testicular interstitial tissue
Published in Andrology (Oxford) (01-03-2014)“…Summary Nicotine is largely consumed as a component of cigarettes. It induces apoptosis, interferes with endocrine function by changing the sex hormones…”
Get full text
Journal Article -
17
A novel strategy to design binding molecules harnessing the modular nature of repeat proteins
Published in FEBS letters (27-03-2003)“…Repeat proteins, such as ankyrin or leucine-rich repeat proteins, are ubiquitous binding molecules, which occur, unlike antibodies, intra- and extracellularly…”
Get full text
Journal Article -
18
Ensovibep, a SARS‐CoV‐2 antiviral designed ankyrin repeat protein, is safe and well tolerated in healthy volunteers: Results of a first‐in‐human, ascending single‐dose Phase 1 study
Published in British journal of clinical pharmacology (01-07-2023)“…Aims This study aimed to assess safety, tolerability, pharmacokinetic (PK) and pharmacodynamic (PD) effects of ensovibep, a designed ankyrin repeat protein…”
Get full text
Journal Article -
19
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants
Published in Nature biotechnology (01-12-2022)“…The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with potential resistance to existing drugs emphasizes the need for new…”
Get full text
Journal Article -
20
Treatment of Exudative Age-Related Macular Degeneration with a Designed Ankyrin Repeat Protein that Binds Vascular Endothelial Growth Factor: a Phase I/II Study
Published in American journal of ophthalmology (01-10-2014)“…Purpose To evaluate the safety, tolerability and bioactivity of ascending doses of MP0112, a designed ankyrin repeat protein (DARPin) that binds with high…”
Get full text
Journal Article